General Dynamics Information Technology, a business unit of General Dynamics (GD), said it was awarded a $41.8 million task order by the U.S. Army Medical Research Materiel Command to provide support services for vaccine, drug and medical device development programs to the U.S. Army Medical Materiel Development Activity.
This task order was awarded under the TRICARE Evaluation, Analysis and Management Support or TEAMS contract vehicle and has a term of four years and seven months. USAMMDA is the U.S. Department of Defense's advanced medical materiel development activity for products designed to protect and preserve the lives of service members.
General Dynamics said it will deliver a wide range of services to help the USAMMDA guide new medical technologies through the U.S. Food and Drug Administration regulatory and certification process and develop plans to bring these new products into service.
General Dynamics said it has partnered with Tunnell Government Services Inc., a life sciences technical services consulting leader in biotechnology, medical devices and pharmaceutical product development, on this contract. The companies will provide health, medical research, clinical trial and regulatory expertise as well as information, acquisition and program management support services.
General Dynamics anticipates hiring more than 30 new employees to perform this work at Fort Detrick in Frederick, Md. The company has supported the USAMMDA for four years under a task order issued by the U.S. Army Medical Research Acquisition Activity.
For comments and feedback contact: editorial@rttnews.com
Business News